300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Enterprise Software
Local
Health Care
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Tunisia
Sweden
Oceania
Puerto Rico
Oman
Poland
Colombia
Cameroon
Guernsey
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Estonia
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Lucion, VC Fund

Lucion

VC Fund

Jinan, China

Lucion is an influential professional venture capital institute.

Total investments:
60
Last investment:
Lead investor:
45%

Last updated:

Industries Lucion invests in

BiotechnologyManufacturingMedicalHealth CareSoftware

Stages Lucion invests in

Series ASeries BFunding RoundSeedSeries C

Countries Lucion invests in

China

Round sizes

Series A $1.4M–$539MSeries B $2.8M–$144M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$1.4M–$539M
Series B
$2.8M–$144M

Investment Focus

Industry

  • Biotechnology 11 (18%)
  • Manufacturing 11 (18%)
  • Medical 9 (15%)
  • Health Care 8 (13%)
  • Software 5 (8%)
See all 55 industries →

Stage

  • Series A 15 (25%)
  • Series B 8 (13%)
  • Funding Round 6 (10%)
  • Seed 5 (8%)
  • Series C 5 (8%)
See all 10 stages →

Team

NameTitleInvestmentsLinksEmail
Bozhe Liu General Manager & Director
General Manager & Director Total investments: 0 Find email
Du Lin Partner
Partner Total investments: 3 Find email

Investments

CompanyDescriptionRoundLinks
Boden Intelligence Boden Intelligence
BodenAI focuses on providing customers with high-quality data services, mainly providing a full range of process services Series A / May 31, 2026
Robot Era Robot Era
Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes. $200M / Venture - Series Unknown / Apr 27, 2026
Oricell Therapeutics Oricell Therapeutics
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy. $110M / Venture - Series Unknown / Apr 09, 2026
Wutong Sensing Control
Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics. Series A / Feb 28, 2026
Xinge Video Xinge Video
Xinge Video offers services connected to the smart view big data solution and specializes in the connection, management, calculation, and use of video resources for government and corporate customers. Series B / Feb 03, 2026
Juwei Technology Juwei Technology
Juwei Technology is one of the “Four Little Dogs of Hangzhou,” a nickname given to a group of fast-growing, innovative tech startups from Hangzhou that are seen as emerging leaders in China’s next generation of technology companies. $14.4M / Series A / Jan 23, 2026
Haier New Energy Haier New Energy
Haier New Energy expands green and low-carbon solutions under the background of the "dual carbon" goal. $143.6M / Series B / Jan 19, 2026
Tianqing Sky Tianqing Sky
Tianqing Sky is an unmanned aerial platform developer, primarily involved in the development, and mass manufacture of advanced unmanned aerial systems. $14M / Series A / Sep 28, 2025
Zhongke Jilian Optoelectronics Zhongke Jilian Optoelectronics
Zhongke Jilian Optoelectronics is an optoelectronic integrated device solutions company that provides the manufacturing of core optoelectronic chips and devices. Series B / Sep 01, 2025
Glycogene Glycogene
Glycogene specializing in directed evolution, and specialists in nucleic acid chemistry. $13.9M / Series B / Aug 14, 2025
See all 60 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Enterprise Software
Local
Health Care
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Tunisia
Sweden
Oceania
Puerto Rico
Oman
Poland
Colombia
Cameroon
Guernsey
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Estonia
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Lucion invest in?

Lucion invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A and Series B stage. Most of the 60 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Lucion's check size?

Lucion typically joins rounds of $1.4M–$539M at Series A and $2.8M–$144M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lucion participates in.

How do I contact Lucion?

Public channels for Lucion include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Lucion?

The team at Lucion includes Bozhe Liu (General Manager & Director) and Du Lin (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Lucion Lucion Find emails